van der Poel CL - Search Results

1

Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies.

Vrielink H, van der Poel CL, Reesink HW. Vrielink H, et al. Among authors: van der poel cl. Vox Sang. 1995;68(4):251-2. doi: 10.1111/j.1423-0410.1995.tb02584.x. Vox Sang. 1995. PMID: 7660648 No abstract available.

2

Blood donor screening or 'over-screening': how far to go in avoiding transmission of infectious agents?

Reesink HW, Nydegger UE, Tegtmeier GE, Barbara J, Seidl S, Woodfield DG, Okochi K, Couroucé AM, Van der Poel CL. Reesink HW, et al. Among authors: van der poel cl. Vox Sang. 1992;63(1):59-69. doi: 10.1111/j.1423-0410.1992.tb01221.x. Vox Sang. 1992. PMID: 1329352 No abstract available.

3

Evaluation of a new HTLV-I/II polymerase chain reaction.

Vrielink H, Zaaijer HL, Cuypers HT, van der Poel CL, Woerdeman M, Lelie PN, Winkel C, Reesink HW. Vrielink H, et al. Among authors: van der poel cl. Vox Sang. 1997;72(3):144-7. doi: 10.1046/j.1423-0410.1997.7230144.x. Vox Sang. 1997. PMID: 9145484

4

Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands.

Van der Poel CL, Reesink HW, Mauser-Bunschoten EP, Kaufmann RH, Leentvaar-Kuypers A, Chamuleau RA, Schaasberg W, Bakker E, Exel-Oehlers PJ, Theobalds I, et al. Van der Poel CL, et al. Vox Sang. 1991;61(1):30-6. doi: 10.1111/j.1423-0410.1991.tb00923.x. Vox Sang. 1991. PMID: 1949707

5

Blood donors with indeterminate anti-p24gag reactivity in HIV-1 western blot: absence of infectivity to transfused patients and in virus culture.

van der Poel CL, Lelie PN, Reesink HW, van Exel-Oehlers PJ, Tersmette M, van den Akker R, Gonzalves M, Huisman JG. van der Poel CL, et al. Among authors: van den akker r, van exel oehlers pj. Vox Sang. 1989;56(3):162-7. doi: 10.1111/j.1423-0410.1989.tb02020.x. Vox Sang. 1989. PMID: 2567091

6

Diagnosis and prevalence of HIV-2 antibodies in different population subsets in The Netherlands.

van der Poel CL, Lelie PN, Reesink HW, Couroucé AM, Cot MC, Exel-Oehlers PJ, Theobalds I, Buitenwerf J, Cameron A, Huisman JG. van der Poel CL, et al. Vox Sang. 1989;57(4):249-53. doi: 10.1111/j.1423-0410.1989.tb00837.x. Vox Sang. 1989. PMID: 2575826

7

Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAs.

Vrielink H, Zaaijer HL, Reesink HW, van der Poel CL, Cuypers HT, Lelie PN. Vrielink H, et al. Among authors: van der poel cl. Vox Sang. 1995;69(1):14-7. doi: 10.1111/j.1423-0410.1995.tb00341.x. Vox Sang. 1995. PMID: 7483486 Clinical Trial.

8

Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report.

Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Lelie PN. Vrielink H, et al. Among authors: van der poel cl. Vox Sang. 1995;68(1):55-6. doi: 10.1111/j.1423-0410.1995.tb02546.x. Vox Sang. 1995. PMID: 7536990

9

New strip immunoblot for the confirmation of HTLV-I/II infection.

Vrielink H, Zaaijer HL, Van der Poel CL, Quan S, Cuypers HT, Rios M, Lelie PN, Polito A, Sra K, DiNello R, Pichuantes S, Larson D, Reesink HW. Vrielink H, et al. Among authors: van der poel cl. Vox Sang. 1996;70(2):114-6. doi: 10.1111/j.1423-0410.1996.tb01303.x. Vox Sang. 1996. PMID: 8801759

10

Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products.

Vrielink H, Reésink HW, Zaaijer HL, Scholten E, Kremer LC, Cuypers HT, Lelie PN, van Oers MH, van der Poel CL. Vrielink H, et al. Among authors: van oers mh, van der poel cl. Vox Sang. 1997;72(2):67-70. doi: 10.1046/j.1423-0410.1997.7220067.x. Vox Sang. 1997. PMID: 9088071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters